Bora CDMO Bora CDMO

X

CAS 7682-20-4 manufacturers and suppliers on PharmaCompass

PharmaCompass
(2S)-2-aminobutanamide;hydrochloride
Also known as: 7682-20-4, (s)-2-aminobutyramide hydrochloride, H-abu-nh2 hcl, (s)-2-aminobutanamide hydrochloride, L-2-aminobutanamide hydrochloride, (s)-(+)-2-aminobutanamide hydrochloride
Molecular Formula
C4H11ClN2O
Molecular Weight
138.59  g/mol
InChI Key
HDBMIDJFXOYCGK-DFWYDOINSA-N
FDA UNII
2C1V4527RJ

1 2D Structure

(2S)-2-aminobutanamide;hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-2-aminobutanamide;hydrochloride
2.1.2 InChI
InChI=1S/C4H10N2O.ClH/c1-2-3(5)4(6)7;/h3H,2,5H2,1H3,(H2,6,7);1H/t3-;/m0./s1
2.1.3 InChI Key
HDBMIDJFXOYCGK-DFWYDOINSA-N
2.1.4 Canonical SMILES
CCC(C(=O)N)N.Cl
2.1.5 Isomeric SMILES
CC[C@@H](C(=O)N)N.Cl
2.2 Other Identifiers
2.2.1 UNII
2C1V4527RJ
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 7682-20-4

2. (s)-2-aminobutyramide Hydrochloride

3. H-abu-nh2 Hcl

4. (s)-2-aminobutanamide Hydrochloride

5. L-2-aminobutanamide Hydrochloride

6. (s)-(+)-2-aminobutanamide Hydrochloride

7. (2s)-2-aminobutanamide;hydrochloride

8. L-2-aminobutanamide, Hcl

9. Butanamide, 2-amino-, Monohydrochloride, (2s)-

10. L-homoalanylamide Hcl

11. 141978-61-2

12. 2c1v4527rj

13. Levetiracetam Related Compound B [usp-rs]

14. Butanamide, 2-amino-, Monohydrochloride, (s)-

15. Butanamide, 2-amino-, Hydrochloride (1:1), (2s)-

16. H-abu(2)-nh2 Hcl

17. (s)-2-aminobutanamide Hcl

18. (s)-2-amino Butanamide Hcl

19. (s)-2-amino-butanamide Hcl

20. Mfcd00136565

21. H-abu-nh2hcl

22. (s)-2-amino-butanamide Hydrochloride

23. S (+)-2-aminobutyramide Hydrochloride

24. L-2-aminobutanamide Hcl

25. Schembl373444

26. Unii-2c1v4527rj

27. L-homoalanylamide Hydrochloride

28. (s)-2-amino-butylactamide Hcl

29. Dtxsid10474839

30. S-2-aminobutanamide Hydrochloride

31. Act02761

32. Cs-b0864

33. H-abu-nh2 Hydrochloride, Aldrichcpr

34. Akos015910759

35. Ds-1209

36. Butanamide,2-amino-,hydrochloride(1:1)

37. Ac-23986

38. Am20100759

39. (s)-2-aminobutanamide Hydrochloride [usp-rs]

40. (s)-(+)-2-aminobutanamide Hydrochloride, 97%

41. 682a204

42. A935960

43. (2s)-2-aminobutanamide--hydrogen Chloride (1/1)

44. Butyramide, 2-amino-, Monohydrochloride, L-

45. Q-102786

46. Levetiracetam Related Compound B, United States Pharmacopeia (usp) Reference Standard

2.4 Create Date
2006-12-11
3 Chemical and Physical Properties
Molecular Weight 138.59 g/mol
Molecular Formula C4H11ClN2O
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Exact Mass138.0559907 g/mol
Monoisotopic Mass138.0559907 g/mol
Topological Polar Surface Area69.1 Ų
Heavy Atom Count8
Formal Charge0
Complexity72.1
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
Flag India
Digital Content Digital Content
URL Supplier Web Content
7682-20-4
Established in 2003 with small pilot plant and came in to commercial production in 2013 in the name of Al...
Established in 2003 with small pilot plant and came in to commercial production in 2013 in the name of Allchem Laboratories, it is an independent privately owned company.Name changed from Allchem Laboratories to Allchem Lifescience Pvt. Ltd in April-2017.We are Allchem Lifescience Pvt Ltd., a fully cGMP compliant pharmaceutical intermediates plant located in the outskirts of Vadodara, Gujarat, India. (Location :400 km north of Mumbai at Vadodara, Gujarat, INDIA).
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
7682-20-4
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
7682-20-4
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
7682-20-4
We specialize in the supply of API and API related intermediates and services. A significant part of our ...
We specialize in the supply of API and API related intermediates and services. A significant part of our business comes from the process/production development tailored to our customers' requirement.We see our core-value in our top-of-the-rank R&D capabilities, strict quality system, fast communication with accuracy and 15years of continued dedication to pharmaceutical and chemical industries.We take pride in the long term partnership with our reputed customers, and feel truly fortunate to work with mutual and respect. We constantly strive to keep up with their ever increasing expectation, to ensure we are worthy of their trust and reliance.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
7682-20-4
We are a top producer of Pharmaceutical Intermediates, Specialty Chemicals, and More, with origins dating...
We are a top producer of Pharmaceutical Intermediates, Specialty Chemicals, and More, with origins dating back to 1998. Globally renowned for its Organic Compounds, Inorganic Compounds, Industrial Acids, Industrial Chemicals, Zinc Acetates, Calcium Chloride Dihydrates, Speciality Chemicals, and other products, Sagar Life Science Private Limited is a customer-centric business with a primary focus on innovations, quality, and customization. Since sustainability is among our core values, we concentrate on improving the efficiency of our processes to manufacture sustainable results.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
7682-20-4
Sandoo Pharmaceuticals and Chemcials Co.,Ltd was established in 2009, with a young and active team, locat...
Sandoo Pharmaceuticals and Chemcials Co.,Ltd was established in 2009, with a young and active team, located in Ningbo, China. Specializes in exporting and importing pharmaceutical intermediates and chemical products as well as active pharmaceutical ingredients.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
141978-61-2
Zhejiang Bamboo Pharmaceuticals is a new, innovative, green, high-grade pharmaceutical intermediate, API ...
Zhejiang Bamboo Pharmaceuticals is a new, innovative, green, high-grade pharmaceutical intermediate, API and oral solid formulation pharmaceutical manufacturer which was established in 2020. The company is positioned as a modern and regulatory pharmaceutical company with API and formulation drug. The formulation drug are mainly sold to the domestic market, and the goal is to become one of the largest supplier of Chinese "4 + 7" volume procurement in China.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
7682-20-4
Zhejiang Bamboo Pharmaceuticals is a new, innovative, green, high-grade pharmaceutical intermediate, API ...
Zhejiang Bamboo Pharmaceuticals is a new, innovative, green, high-grade pharmaceutical intermediate, API and oral solid formulation pharmaceutical manufacturer which was established in 2020. The company is positioned as a modern and regulatory pharmaceutical company with API and formulation drug. The formulation drug are mainly sold to the domestic market, and the goal is to become one of the largest supplier of Chinese "4 + 7" volume procurement in China.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY